{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,11,2]],"date-time":"2025-11-02T16:34:23Z","timestamp":1762101263297},"reference-count":41,"publisher":"Oxford University Press (OUP)","issue":"2","license":[{"start":{"date-parts":[[2012,4,3]],"date-time":"2012-04-03T00:00:00Z","timestamp":1333411200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/academic.oup.com\/journals\/pages\/open_access\/funder_policies\/chorus\/standard_publication_model"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2012,4,3]]},"abstract":"<jats:title>Summary<\/jats:title><jats:p>Clinically available anti-tumour necrosis factor (TNF) biologics, which inhibit both soluble (sTNF) and transmembrane forms (tmTNF) of TNF, eliminating all TNF signalling, have successfully treated autoimmune diseases including uveitis. These have potentially serious side effects such as reactivation of latent Mycobacterium tuberculosis and, therefore, more specific inhibition of TNF signalling pathways may maintain clinical efficacy while reducing adverse effects. To determine the effects of specific pharmacological inhibition of sTNF on macrophage activation and migration, we used a mouse model of uveitis (experimental autoimmune uveoretinitis; EAU). We show that selective inhibition of sTNF is sufficient to suppress EAU by limiting inflammatory CD11b+ macrophages and CD4+ T cell migration into the eye. However, inhibition of both sTNF and tmTNF is required to inhibit interferon-\u03b3-induced chemokine receptor 2, CD40, major histocompatibility complex class II and nitric oxide (NO) up-regulation, and signalling via tmTNF is sufficient to mediate tissue damage. In confirmation, intravitreal inhibition of sTNF alone did not suppress disease, and inflammatory cells that migrated into the eye were activated, generating NO, thus causing structural damage to the retina. In contrast, intravitreal inhibition of both sTNF and tmTNF suppressed macrophage activation and therefore disease. We conclude that sTNF is required for inflammatory cell infiltration into target tissue, but at the tissue site inhibition of both sTNF and tmTNF is required to inhibit macrophage activation and to protect from tissue damage.<\/jats:p>","DOI":"10.1111\/j.1365-2249.2012.04567.x","type":"journal-article","created":{"date-parts":[[2012,2,2]],"date-time":"2012-02-02T03:31:30Z","timestamp":1328153490000},"page":"165-177","source":"Crossref","is-referenced-by-count":25,"title":["Tumour necrosis factor-mediated macrophage activation in the target organ is critical for clinical manifestation of uveitis"],"prefix":"10.1093","volume":"168","author":[{"given":"T K","family":"Khera","sequence":"first","affiliation":[{"name":"School of Cellular and Molecular Medicine"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"D A","family":"Copland","sequence":"additional","affiliation":[{"name":"Academic Unit of Ophthalmology, School of Clinical Sciences, University of Bristol, Bristol, UK"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"J","family":"Boldison","sequence":"additional","affiliation":[{"name":"School of Cellular and Molecular Medicine"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"P J P","family":"Lait","sequence":"additional","affiliation":[{"name":"Academic Unit of Ophthalmology, School of Clinical Sciences, University of Bristol, Bristol, UK"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"D E","family":"Szymkowski","sequence":"additional","affiliation":[{"name":"Xencor Inc., Monrovia, CA, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"A D","family":"Dick","sequence":"additional","affiliation":[{"name":"School of Cellular and Molecular Medicine"},{"name":"Academic Unit of Ophthalmology, School of Clinical Sciences, University of Bristol, Bristol, UK"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"L B","family":"Nicholson","sequence":"additional","affiliation":[{"name":"School of Cellular and Molecular Medicine"},{"name":"Academic Unit of Ophthalmology, School of Clinical Sciences, University of Bristol, Bristol, UK"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"286","published-online":{"date-parts":[[2012,4,3]]},"reference":[{"key":"2021122708380904100_b1","doi-asserted-by":"crossref","first-page":"110","DOI":"10.1016\/S0167-5699(99)01573-X","article-title":"Tumor necrosis factor: a master-regulator of leukocyte movement","volume":"21","author":"Sedgwick","year":"2000","journal-title":"Immunol Today"},{"key":"2021122708380904100_b2","doi-asserted-by":"crossref","first-page":"335","DOI":"10.1016\/j.cytogfr.2007.04.002","article-title":"How TNF was recognized as a key mechanism of disease","volume":"18","author":"Clark","year":"2007","journal-title":"Cytokine Growth Factor Rev"},{"key":"2021122708380904100_b3","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.autrev.2007.03.001","article-title":"Inflammatory molecules: a target for treatment of systemic autoimmune diseases","volume":"7","author":"Tincani","year":"2007","journal-title":"Autoimmun Rev"},{"key":"2021122708380904100_b4","doi-asserted-by":"crossref","first-page":"2321","DOI":"10.4049\/jimmunol.0901340","article-title":"TNFR1-dependent regulation of myeloid cell function in experimental autoimmune uveoretinitis","volume":"183","author":"Raveney","year":"2009","journal-title":"J Immunol"},{"key":"2021122708380904100_b5","doi-asserted-by":"crossref","first-page":"1585","DOI":"10.1084\/jem.186.9.1585","article-title":"Critical points of tumor necrosis factor action in central nervous system autoimmune inflammation defined by gene targeting","volume":"186","author":"Korner","year":"1997","journal-title":"J Exp Med"},{"key":"2021122708380904100_b6","doi-asserted-by":"crossref","first-page":"1517","DOI":"10.1084\/jem.187.9.1517","article-title":"Challenging cytokine redundancy: inflammatory cell movement and clinical course of experimental autoimmune encephalomyelitis are normal in lymphotoxin-deficient, but not tumor necrosis factor-alpha deficient, mice","volume":"187","author":"Riminton","year":"1998","journal-title":"J Exp Med"},{"key":"2021122708380904100_b7","doi-asserted-by":"crossref","first-page":"7054","DOI":"10.4049\/jimmunol.169.12.7054","article-title":"Interactions between hemopoietically derived TNF and central nervous system-resident glial chemokines underlie initiation of autoimmune inflammation in the brain","volume":"169","author":"Murphy","year":"2002","journal-title":"J Immunol"},{"key":"2021122708380904100_b8","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1006\/jaut.1998.0197","article-title":"Neutralizing TNF-alpha activity modulates T-cell phenotype and function in experimental autoimmune uveoretinitis","volume":"11","author":"Dick","year":"1998","journal-title":"J Autoimmun"},{"key":"2021122708380904100_b9","doi-asserted-by":"crossref","first-page":"1018","DOI":"10.1002\/eji.1830260510","article-title":"Inhibition of tumor necrosis factor activity minimizes target organ damage in experimental autoimmune uveoretinitis despite quantitatively normal activated T cell traffic to the retina","volume":"26","author":"Dick","year":"1996","journal-title":"Eur J Immunol"},{"key":"2021122708380904100_b10","doi-asserted-by":"crossref","first-page":"341","DOI":"10.1006\/exer.2000.0957","article-title":"Interphotoreceptor retinoid binding protein peptide-induced uveitis in B10.RIII mice: characterization of disease parameters and immunomodulation","volume":"72","author":"Hankey","year":"2001","journal-title":"Exp Eye Res"},{"key":"2021122708380904100_b11","doi-asserted-by":"crossref","first-page":"1761","DOI":"10.1167\/iovs.08-3027","article-title":"Local ocular immunomodulation resulting from electrotransfer of plasmid encoding soluble TNF receptors in the ciliary muscle","volume":"50","author":"Kowalczuk","year":"2009","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"2021122708380904100_b12","first-page":"2211","article-title":"Anti-tumor necrosis factor alpha therapy suppresses the induction of experimental autoimmune uveoretinitis in mice by inhibiting antigen priming","volume":"37","author":"Sartani","year":"1996","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"2021122708380904100_b13","doi-asserted-by":"crossref","first-page":"6286","DOI":"10.4049\/jimmunol.175.10.6286","article-title":"A selective role for the TNF p55 receptor in autocrine signaling following IFN-gamma stimulation in experimental autoimmune uveoretinitis","volume":"175","author":"Calder","year":"2005","journal-title":"J Immunol"},{"key":"2021122708380904100_b14","doi-asserted-by":"crossref","first-page":"617","DOI":"10.1016\/j.preteyeres.2004.06.005","article-title":"The role of tumour necrosis factor (TNF-alpha) in experimental autoimmune uveoretinitis (EAU)","volume":"23","author":"Dick","year":"2004","journal-title":"Prog Retin Eye Res"},{"key":"2021122708380904100_b15","doi-asserted-by":"crossref","first-page":"2768","DOI":"10.1002\/eji.200635921","article-title":"Transmembrane TNF protects mutant mice against intracellular bacterial infections, chronic inflammation and autoimmunity","volume":"36","author":"Alexopoulou","year":"2006","journal-title":"Eur J Immunol"},{"key":"2021122708380904100_b16","doi-asserted-by":"crossref","first-page":"533","DOI":"10.1016\/S1074-7613(01)00215-1","article-title":"Membrane-bound TNF supports secondary lymphoid organ structure but is subservient to secreted TNF in driving autoimmune inflammation","volume":"15","author":"Ruuls","year":"2001","journal-title":"Immunity"},{"key":"2021122708380904100_b17","doi-asserted-by":"crossref","first-page":"1872","DOI":"10.4049\/jimmunol.179.3.1872","article-title":"Dominant-negative inhibitors of soluble TNF attenuate experimental arthritis without suppressing innate immunity to infection","volume":"179","author":"Zalevsky","year":"2007","journal-title":"J Immunol"},{"key":"2021122708380904100_b18","doi-asserted-by":"crossref","first-page":"1895","DOI":"10.1126\/science.1081297","article-title":"Inactivation of TNF signaling by rationally designed dominant-negative TNF variants","volume":"301","author":"Steed","year":"2003","journal-title":"Science"},{"key":"2021122708380904100_b19","doi-asserted-by":"crossref","first-page":"5347","DOI":"10.4049\/jimmunol.160.11.5347","article-title":"Alternative metabolic states in murine macrophages reflected by the nitric oxide synthase\/arginase balance: competitive regulation by CD4+ T cells correlates with Th1\/Th2 phenotype","volume":"160","author":"Munder","year":"1998","journal-title":"J Immunol"},{"key":"2021122708380904100_b20","doi-asserted-by":"crossref","first-page":"5458","DOI":"10.1167\/iovs.08-2348","article-title":"The clinical time\u2013course of experimental autoimmune uveoretinitis using topical endoscopic fundal imaging with histologic and cellular infiltrate correlation","volume":"49","author":"Copland","year":"2008","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"2021122708380904100_b21","doi-asserted-by":"crossref","first-page":"319","DOI":"10.1016\/j.exer.2008.06.012","article-title":"A clinical grading system for retinal inflammation in the chronic model of experimental autoimmune uveoretinitis using digital fundus images","volume":"87","author":"Xu","year":"2008","journal-title":"Exp Eye Res"},{"key":"2021122708380904100_b22","doi-asserted-by":"crossref","first-page":"4008","DOI":"10.1167\/iovs.08-1848","article-title":"The B subunit of Escherichia coli heat-labile enterotoxin inhibits Th1 but not Th17 cell responses in established autoimmune uveoretinitis","volume":"49","author":"Raveney","year":"2008","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"2021122708380904100_b23","doi-asserted-by":"crossref","DOI":"10.1080\/02713689808951224","volume-title":"Marrow-derived activated macrophages are required during the effector phase of experimental autoimmune uveoretinitis in rats","author":"Forrester","year":"1998"},{"key":"2021122708380904100_b24","doi-asserted-by":"crossref","first-page":"3034","DOI":"10.1167\/iovs.02-1156","article-title":"Neutralizing tumor necrosis factor-alpha activity suppresses activation of infiltrating macrophages in experimental autoimmune uveoretinitis","volume":"44","author":"Robertson","year":"2003","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"2021122708380904100_b25","first-page":"2250","article-title":"Retinal microenvironment controls resident and infiltrating macrophage function during uveoretinitis","volume":"43","author":"Robertson","year":"2002","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"2021122708380904100_b26","doi-asserted-by":"crossref","first-page":"354","DOI":"10.1016\/j.jaut.2008.08.006","article-title":"Analysis of retinal cellular infiltrate in experimental autoimmune uveoretinitis reveals multiple regulatory cell populations","volume":"31","author":"Kerr","year":"2008","journal-title":"J Autoimmun"},{"key":"2021122708380904100_b27","doi-asserted-by":"crossref","first-page":"3273","DOI":"10.4049\/jimmunol.170.6.3273","article-title":"Monocytes are potent facilitators of alveolar neutrophil emigration during lung inflammation: role of the CCL2-CCR2 axis","volume":"170","author":"Maus","year":"2003","journal-title":"J Immunol"},{"key":"2021122708380904100_b28","doi-asserted-by":"crossref","first-page":"6843","DOI":"10.4049\/jimmunol.0903987","article-title":"An independent subset of TLR expressing CCR2-dependent macrophages promotes colonic inflammation","volume":"184","author":"Platt","year":"2010","journal-title":"J Immunol"},{"key":"2021122708380904100_b29","doi-asserted-by":"crossref","first-page":"1192","DOI":"10.1172\/JCI40310","article-title":"CCR2 mediates hematopoietic stem and progenitor cell trafficking to sites of inflammation in mice","volume":"120","author":"Si","year":"2010","journal-title":"J Clin Invest"},{"key":"2021122708380904100_b30","doi-asserted-by":"crossref","first-page":"961","DOI":"10.2310\/JIM.0b013e31821c0242","article-title":"Blockage of TNF-alpha by infliximab reduces CCL2 and CCR2 levels in patients with rheumatoid arthritis","volume":"59","author":"Xia","year":"2011","journal-title":"J Invest Med"},{"key":"2021122708380904100_b31","doi-asserted-by":"crossref","first-page":"e21772","DOI":"10.1371\/journal.pone.0021772","article-title":"Why CCR2 and CCR5 blockade failed and why CCR1 blockade might still be effective in the treatment of rheumatoid arthritis","volume":"6","author":"Lebre","year":"2011","journal-title":"PLoS ONE"},{"key":"2021122708380904100_b32","doi-asserted-by":"crossref","first-page":"1931","DOI":"10.1002\/art.23591","article-title":"Modulation of CCR2 in rheumatoid arthritis: a double-blind, randomized, placebo-controlled clinical trial","volume":"58","author":"Vergunst","year":"2008","journal-title":"Arthritis Rheum"},{"key":"2021122708380904100_b33","doi-asserted-by":"crossref","first-page":"4288","DOI":"10.1167\/iovs.09-3434","article-title":"Development of experimental autoimmune uveitis: efficient recruitment of monocytes is independent of CCR2","volume":"50","author":"Dagkalis","year":"2009","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"2021122708380904100_b34","doi-asserted-by":"crossref","first-page":"218","DOI":"10.1136\/bjo.2005.077875","article-title":"Analysis of corneal inflammation induced by cauterisation in CCR2 and MCP-1 knockout mice","volume":"90","author":"Oshima","year":"2006","journal-title":"Br J Ophthalmol"},{"key":"2021122708380904100_b35","doi-asserted-by":"crossref","first-page":"579","DOI":"10.1016\/S0140-6736(02)07714-0","article-title":"Drug-induced systemic lupus erythematosus associated with etanercept therapy","volume":"359","author":"Shakoor","year":"2002","journal-title":"Lancet"},{"key":"2021122708380904100_b36","doi-asserted-by":"crossref","first-page":"204","DOI":"10.1097\/00002281-200205000-00002","article-title":"Tumor necrosis factor-alpha antagonists for the treatment of rheumatic diseases","volume":"14","author":"Criscione","year":"2002","journal-title":"Curr Opin Rheumatol"},{"key":"2021122708380904100_b37","doi-asserted-by":"crossref","first-page":"170","DOI":"10.1167\/iovs.03-0659","article-title":"Anti-TNFalpha therapy modulates the phenotype of peripheral blood CD4+ T cells in patients with posterior segment intraocular inflammation","volume":"45","author":"Greiner","year":"2004","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"2021122708380904100_b38","doi-asserted-by":"crossref","first-page":"1098","DOI":"10.1056\/NEJMoa011110","article-title":"Tuberculosis associated with infliximab, a tumor necrosis factor-alpha neutralizing agent","volume":"345","author":"Keane","year":"2001","journal-title":"N Engl J Med"},{"key":"2021122708380904100_b39","doi-asserted-by":"crossref","first-page":"b2480","DOI":"10.1136\/bmj.b2480","article-title":"Overall and cancer related mortality among patients with ocular inflammation treated with immunosuppressive drugs: retrospective cohort study","volume":"339","author":"Kempen","year":"2009","journal-title":"BMJ"},{"key":"2021122708380904100_b40","doi-asserted-by":"crossref","first-page":"1109","DOI":"10.1016\/S0002-9440(10)62331-0","article-title":"Contribution of transmembrane tumor necrosis factor to host defense against Mycobacterium bovis bacillus Calmette\u2013Gu\u00e9rin and Mycobacterium tuberculosis infections","volume":"166","author":"Olleros","year":"2005","journal-title":"Am J Pathol"},{"key":"2021122708380904100_b41","doi-asserted-by":"crossref","first-page":"1053","DOI":"10.1086\/597204","article-title":"Dominant-negative tumor necrosis factor protects from Mycobacterium bovis bacillus Calmette\u2013Gu\u00e9rin (BCG) and endotoxin-induced liver injury without compromising host immunity to BCG and Mycobacterium tuberculosis","volume":"199","author":"Olleros","year":"2009","journal-title":"J Infect Dis"}],"container-title":["Clinical and Experimental Immunology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1111%2Fj.1365-2249.2012.04567.x","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/academic.oup.com\/cei\/article-pdf\/168\/2\/165\/41907725\/j.1365-2249.2012.04567.x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/cei\/article-pdf\/168\/2\/165\/41907725\/j.1365-2249.2012.04567.x.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,6,14]],"date-time":"2023-06-14T07:24:19Z","timestamp":1686727459000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/cei\/article\/168\/2\/165\/6428938"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2012,4,3]]},"references-count":41,"journal-issue":{"issue":"2","published-online":{"date-parts":[[2012,4,3]]},"published-print":{"date-parts":[[2012,4,3]]}},"URL":"https:\/\/doi.org\/10.1111\/j.1365-2249.2012.04567.x","relation":{},"ISSN":["0009-9104","1365-2249"],"issn-type":[{"value":"0009-9104","type":"print"},{"value":"1365-2249","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2012,5]]},"published":{"date-parts":[[2012,4,3]]}}}